We are live on ! Find out more
Progeny 3 Inc

Progeny 3 Inc Portfolio holdings

AUM $1.94B Turnover 15.15%
1-Year Est. Return 19.13%
 

Progeny 3 is a family office that handles investment management, tax reporting and estate planning for the Smith Hemingway family, owners of the port operator Carrix. Jon Hemingway, who chaired Carrix, led its creation in 2007. That was the year the family sold part of its interest in Carrix to a financial partner.

This Fund
S&P 500
This Quarter Est. Return
+6.05%
1 Year Est. Return
+19.13%
3 Year Est. Return
+96.79%
5 Year Est. Return
+137.95%
10 Year Est. Return
+356.12%
AUM
$1.94B
AUM Growth
+$68.2M
Cap. Flow
-$3.4M
Cap. Flow %
-0.18%
Top 10 Hldgs %
60.56%
Holding
33
New
1
Increased
8
Reduced
2
Closed
4
Avg Time Held
2.8 years
Top 10 Avg Time Held
2 years
Top 20 Avg Time Held
2.9 years

Top Buys

Rank Stock Value
1
AROC icon
Archrock
AROC
+$38.3M
2
POOL icon
Pool Corp
POOL
+$25.9M
3
CLBT icon
Cellebrite
CLBT
+$11.5M
4
AMZN icon
Amazon
AMZN
+$5.15M
5
SSNC icon
SS&C Technologies
SSNC
+$5.02M

Sector Composition

Rank Sector Weight
1 Energy 31.42%
2 Industrials 17.23%
3 Financials 16.5%
4 Technology 10.45%
5 Materials 9.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
NRP icon
26
Natural Resource Partners
NRP
$1.59B
$22.3M 1.15%
229,463
-83,060
-27% -$9.11M
2024 Q4
6 quarters
BXSL icon
27
Blackstone Secured Lending
BXSL
$5.58B
$18.3M 0.94%
772,156
– –
2024 Q4
6 quarters
HCC icon
28
Warrior Met Coal
HCC
$4.53B
$4.4M 0.23%
54,235
– –
2021 Q3
19 quarters
ASND icon
29
Ascendis Pharma A/S
ASND
$16.9B
$1.39M 0.07%
5,230
– –
2025 Q4
2 quarters
ABVX icon
30
Abivax
ABVX
$7.88B
– –
-12,240
Closed -$1.36M –
CRNX icon
31
DELISTED
Crinetics Pharmaceuticals
CRNX
– –
-24,000
Closed -$872K –
GFL icon
32
GFL Environmental
GFL
$18.5B
– –
-1,937,200
Closed -$80.8M –
PCVX icon
33
Vaxcyte
PCVX
$10.5B
– –
-23,300
Closed -$1.35M –

Similar funds

Progeny 3 Inc's Q2 2026 Portfolio in Review

As of Q2 2026, Progeny 3 Inc held 33 positions worth $1.94B, up 3.6% from $1.87B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Progeny 3 Inc's Q2 2026 filing shows 1 new, 8 increased, 2 reduced and 4 closed positions. Its largest new stake was Archrock: 1,041,625 shares worth $42.4M. The largest sale was GFL Environmental, an estimated $80.8M.

By sector, the portfolio is most concentrated in Energy at 31% of assets, down from 33% a quarter earlier, followed by Industrials and Financials.

  • Progeny 3 Inc's largest Q2 2026 buy was Archrock: 1,041,625 shares worth $42.4M.
  • Progeny 3 Inc added most to Pool Corp in Q2 2026, an estimated $25.9M increase.
  • Progeny 3 Inc's biggest Q2 2026 reduction was Natural Resource Partners, cutting an estimated $9.11M.
  • Progeny 3 Inc fully exited GFL Environmental in Q2 2026, selling an estimated $80.8M.
  • Progeny 3 Inc's ten largest holdings make up 61% of its $1.94B portfolio in Q2 2026.
  • Progeny 3 Inc opened 1 new position and closed 4 in Q2 2026.
  • Progeny 3 Inc's portfolio value rose 3.6% quarter-over-quarter to $1.94B.

Based on Progeny 3 Inc's 13F filing for Q2 2026, filed 14 Aug 2026.